NeuroPace (NPCE) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to -$0.11.
- NeuroPace's EPS (Weighted Average and Diluted) rose 4210.53% to -$0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.75, marking a year-over-year increase of 2424.24%. This contributed to the annual value of -$0.94 for FY2024, which is 2580.51% up from last year.
- Latest data reveals that NeuroPace reported EPS (Weighted Average and Diluted) of -$0.11 as of Q3 2025, which was up 4210.53% from -$0.26 recorded in Q2 2025.
- NeuroPace's EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.11 during Q3 2025, with a 5-year trough of -$32.73 in Q1 2021.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.34 (2021), whereas its average is -$2.03.
- Per our database at Business Quant, NeuroPace's EPS (Weighted Average and Diluted) soared by 9889.5% in 2021 and then crashed by 4117.65% in 2022.
- Quarter analysis of 5 years shows NeuroPace's EPS (Weighted Average and Diluted) stood at -$0.36 in 2021, then dropped by 22.22% to -$0.44 in 2022, then skyrocketed by 50.0% to -$0.22 in 2023, then rose by 19.41% to -$0.18 in 2024, then soared by 37.96% to -$0.11 in 2025.
- Its last three reported values are -$0.11 in Q3 2025, -$0.26 for Q2 2025, and -$0.21 during Q1 2025.